Compugen (CGEN) Non Operating Interest Expenses (2011 - 2012)
Compugen (CGEN) reported Non Operating Interest Expenses of -$1.5 million for Q4 2012, down 15.8% on a YoY basis from -$1.8 million in Q1 2012, and down 15.8% sequentially from -$1.3 million in Q4 2011.
Compugen (CGEN) Non Operating Interest Expenses (2011 - 2012) Analysis & Trends
Compugen (CGEN) has 2 years of Non Operating Interest Expenses data on file, last reported at -$1.5 million in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -220,921.81 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Compugen | 215.59 Mn | 123.84 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | -1.53 Mn |
| Dec 31, 2011 | -1.32 Mn |